Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
18.54
-0.28 (-1.49%)
Apr 9, 2026, 3:00 PM CST
SHA:600079 Market Cap
SHA:600079 has a market cap or net worth of 30.26 billion as of April 9, 2026. Its market cap has decreased by -7.88% in one year.
Market Cap
30.26B
Enterprise Value
36.97B
Revenue
23.96B
Ranking
n/a
PE Ratio
16.26
Stock Price
18.54
Market Cap Chart
Since January 2, 2001, SHA:600079's market cap has increased from 2.30B to 30.26B, an increase of 1,218.11%. That is a compound annual growth rate of 10.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 30.72B | 3.92% |
| Dec 31, 2025 | 29.56B | -21.41% |
| Dec 31, 2024 | 37.61B | -5.96% |
| Dec 29, 2023 | 40.00B | 4.04% |
| Dec 30, 2022 | 38.44B | 6.06% |
| Dec 31, 2021 | 36.25B | -30.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Tongrentang | 38.51B |
| Dong-E-E-Jiao | 36.25B |
| Changchun High-Tech Industry (Group) | 34.97B |
| Shijiazhuang Yiling Pharmaceutical | 28.45B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 28.11B |
| Livzon Pharmaceutical Group | 27.90B |
| Dizal (Jiangsu) Pharmaceutical | 26.74B |
| Chengdu Kanghong Pharmaceutical Group | 26.32B |